Skip to Main content Skip to Navigation
Journal articles

Dietary n-3 PUFA May Attenuate Experimental Colitis

Abstract : Background. Inflammatory bowel diseases (IBD) occurred in genetically predisposed people exposed to environmental triggers. Diet has long been suspected to contribute to the development of IBD. Supplementation with n-3 polyunsaturated fatty acids (PUFA) protects against intestinal inflammation in rodent models while clinical trials showed no benefits. We hypothesized that intervention timing is crucial and dietary fatty acid pattern may influence intestinal environment to modify inflammation genesis. The aim of this study was to evaluate the dietary effect of PUFA composition on intestinal inflammation. Methods. Animals received diet varying in their PUFA composition for four weeks before TNBS-induced colitis. Colon inflammatory markers and gut barrier function parameters were assessed. Inflammatory pathway PCR arrays were determined. Results. n-3 diet significantly decreased colon iNOS, COX-2 expression, IL-6 production, and LTB4 production but tended to decrease colon TNFα production () compared to control diet. Tight junction protein (claudin-1, occludin) expressions and MUC2 and TFF3 mRNA levels were not different among groups. n-9 diet also decreased colon IL-6 production (). Conclusions. Dietary n-3 PUFA influence colitis development by attenuating inflammatory markers. Further research is required to better define dietary advice with a scientific rationale.
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02315973
Contributor : Sabine Douville <>
Submitted on : Tuesday, October 15, 2019 - 8:32:07 AM
Last modification on : Thursday, July 2, 2020 - 3:42:27 AM

Links full text

Identifiers

Collections

Citation

Cloé Charpentier, Ronald Chan, Emmeline Salameh, Khaly Mbodji, Aito Ueno, et al.. Dietary n-3 PUFA May Attenuate Experimental Colitis. Mediators of Inflammation, Hindawi Publishing Corporation, 2018, 2018, pp.1-10. ⟨10.1155/2018/8430614⟩. ⟨hal-02315973⟩

Share

Metrics

Record views

54